<DOC>
	<DOC>NCT01895088</DOC>
	<brief_summary>This is a 2 year follow up study to monitor the long term safety of the ACI 7000PDT in subjects who are still implanted with the ACI and have successfully completed the ACU-P08-020/020A studies.</brief_summary>
	<brief_title>A Continuation Study To Monitor The Long Term Safety Of Patients Completing Protocols ACU-P08-020/020A</brief_title>
	<detailed_description>This is a two year follow up study designed to monitor and obtain long-term safety data of the ACI 7000PDT in subjects who participated and successfully completed the ACU-P08-020/020A studies. Subjects must be able to provide voluntary informed consent, and must sign and be given a copy of the written Informed Consent form prior to participating. This continuation study follows subjects still implanted with the ACI and includes two visits, at 12-month intervals, after subjects have been exited (at Month 36) from the ACU-P08-020/020A studies. The first visit is at Month 48 following implantation followed by a final Month 60 visit. The study parameters being measured at these two visits include: - Specular microscopy - Slit lamp and fundus examination (ocular health) - Corrected and uncorrected visual acuity - Manifest mid-point refraction - Corneal topography - Dry eye assessment - Mesopic and Photopic contrast sensitivity - Adverse events and complications All sites participating in the ACU-P08-020/020A studies were invited to participate in the continuation study.</detailed_description>
	<mesh_term>Presbyopia</mesh_term>
	<criteria>Patients must have completed participation in the ACUP08020/020A clinical trial. Patients must be able to provide voluntary informed consent, and must sign and be given a copy of the written Informed Consent form. Patients who did not complete ACUP08020/020A.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>presbyopia</keyword>
</DOC>